Anthropic's pace of expansion has been breathtaking. Its revenue rose from $41 million in 2023 to $386 million in 2024 and $4 ...
One ETF that can be a great addition to your portfolio is the Vanguard Morningstar Growth ETF ( VUG -2.21%). It has been a ...
Burry's warnings came in pieces. In mid-October, he shared a Wall Street Journal story arguing that CoreWeave's sell-off ...
Shares of MercadoLibre ( MELI -4.75%) were recently trading for about $1,427 apiece -- very close to their 52-week low of ...
Tokenizing corporate share registers could build a recurring revenue base that is less tied to volatile crypto trading ...
The company, like CrowdStrike a grizzled cybersecurity operator, posted revenue that not only notched a new record, but was ...
Its bet on outsourced growing and a new Iowa beverage plant hinges on whether higher-margin drinks can outearn the produce ...
UTI is in the midst of implementing its multi-year "North Star Strategy," aimed at transforming its historical focus on ...
Its proprietary tracking data, built over nearly two decades, is what management says competitors cannot easily replicate.
AMD has been viewed as the No. 2 graphics processing unit (GPU) chipmaker for several years, with Nvidia comfortably holding ...
Spousal benefits are also available to ex-spouses if you were married to a qualifying worker for at least 10 years before ...
However, this once again highlights the strength of Johnson & Johnson's pipeline. The company has successfully expanded its lineup of approved drugs in recent years, with newer launches such as Imaavy ...